SeaStar Medical Announces Board, Officer Changes
Ticker: ICUCW · Form: 8-K · Filed: Jun 10, 2024 · CIK: 1831868
| Field | Detail |
|---|---|
| Company | Seastar Medical Holding CORP (ICUCW) |
| Form Type | 8-K |
| Filed Date | Jun 10, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, corporate-governance, filing
TL;DR
SeaStar Medical is shaking up its leadership team and compensation plans.
AI Summary
SeaStar Medical Holding Corp. announced on June 5, 2024, a series of significant corporate actions including the election of new directors, the appointment of new officers, and changes to compensatory arrangements. The company also filed financial statements and exhibits as part of this report.
Why It Matters
Changes in leadership and compensation structures can signal shifts in company strategy and future performance, impacting investor confidence.
Risk Assessment
Risk Level: medium — Changes in board composition and executive appointments can introduce uncertainty regarding future strategy and operational execution.
Key Players & Entities
- SeaStar Medical Holding Corp. (company) — Registrant
- June 5, 2024 (date) — Date of earliest event reported
FAQ
Who were the newly elected directors?
The filing does not specify the names of the newly elected directors, only that elections occurred.
What specific officer positions were filled or changed?
The filing indicates the appointment of certain officers but does not list the specific positions or names.
What are the details of the new compensatory arrangements?
The filing mentions changes to compensatory arrangements but does not provide specific details within the provided text.
What financial statements and exhibits were filed?
The filing states that financial statements and exhibits were filed, but the specific contents are not detailed in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on June 5, 2024.
Filing Stats: 719 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2024-06-10 08:45:11
Key Financial Figures
- $0.0001 — ich registered Common Stock par value $0.0001 per share ICU The Nasdaq Stock Mark
- $11.50 — sable for one share of Common Stock for $11.50 per share ICUCW The Nasdaq Stock Ma
Filing Documents
- icu-20240605.htm (8-K) — 48KB
- icu-ex99_1.htm (EX-99.1) — 18KB
- img257978346_0.jpg (GRAPHIC) — 5KB
- 0000950170-24-071087.txt ( ) — 228KB
- icu-20240605.xsd (EX-101.SCH) — 47KB
- icu-20240605_htm.xml (XML) — 6KB
01 – Financial Statements and Exhibits
Item 9.01 – Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press release dated June 10, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SeaStar Medical Holding Corporation By: /s/ Eric Schlorff Date: June 10, 2024 Name: Eric Schlorff Title: Chief Executive Officer